Tag

en US- Pagina 693

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

martedì, 21 Febbraio 2023
(Adnkronos) – – Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication –  NEWTON, Mass. and FLORENCE, Italy, Feb. 21, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical

LITEON Technology Reports 2022 EPS of NT$6.19

martedì, 21 Febbraio 2023
(Adnkronos) – High-value Core Businesses Drive Profitable Growth, Demonstrating the Results of Transformation Strategies  TAIPEI, Feb. 21, 2023 /PRNewswire/ — LITEON Technology (2301-tw) reported the fourth quarter sales of NT$43.1 billion, supported